Section Arrow
YDES.NASDAQ
- YD Bio Limited
Quotes are at least 15-min delayed:2026/05/26 08:37 EDT
Pre Market
Last
 --
-- (--)
Bid
4
Ask
6.5
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 4.75
+0.23 (+5.09%)
Day High 
4.75 
Prev. Close
4.52 
1-M High
5.634 
Volume 
4.46K 
Bid
4
Ask
6.5
Day Low
4.5001 
Open
4.625 
1-M Low
4.3697 
Market Cap 
320.16M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.04 
20-SMA 5.11 
50-SMA 5.95 
52-W High 25 
52-W Low 4.3697 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.12/--
Enterprise Value
320.16M
Balance Sheet
Book Value Per Share
-0.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
596.82K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GOVXGeoVax Labs Inc.3.64+0.89+32.36%-- 
Pre Market 3.6968 +0.0568 +1.56%
MTVAMetaVia Inc.3.85+0.98+34.15%-- 
Pre Market 3.345 -0.505 -13.12%
AKTXAkari Therapeutics Plc18.27+13.13+255.45%-- 
Pre Market 13.95 -4.32 -23.65%
LIMNLiminatus Pharma Inc0.1694-0.0766-31.14%-- 
Pre Market 0.1664 -0.003 -1.77%
IOVAIovance Biotherapeutics4.11+0.41+11.08%-- 
Pre Market 4.06 -0.05 -1.22%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.